High prevalence of the GSTM3*A/B polymorphism in sub-Sarahan African populations

AUTOR(ES)

Teixeira, D., Vargens, D., Príncipe, A., Oliveira, E., Amorim, A., Prata, M.J., Suarez-Kurtz, G.

FONTE

Brazilian Journal of Medical and Biological Research

DATA DE PUBLICAÇÃO

2010-07

RESUMO

A 3-bp insertion/deletion polymorphism in intron 6 of GSTM3 (rs1799735, GSTM3*A/*B) affects the activity of the phase 2 xenobiotic metabolizing enzyme GSTM3 and has been associated with increased cancer risk. The GSTM3*B allele is rare or absent in Southeast Asians, occurs in 5-20% of Europeans but was detected in 80% of Bantu from South Africa. The wide genetic diversity among Africans led us to investigate whether the high frequency of GSTM3*B prevailed in other sub-Saharan African populations. In 168 healthy individuals from Angola, Mozambique and the São Tomé e Príncipe islands, the GSTM3*B allele was three times more frequent (0.74-0.78) than the GSTM3*A allele (0.22-0.26), with no significant differences in allele frequency across the three groups. We combined these data with previously published results to carry out a multidimensional scaling analysis, which provided a visualization of the worldwide population affinities based on the GSTM3 *A/*B polymorphism.

Documentos Relacionados

• Glutathione S-transferase M1 (GSTM1) polymorphism in two Brazilian populations
• CCR5D32 mutation in three Brazilian populations of predominantly Sub-Saharan African ancestry
• NOS3 gene intron 4 a/b polymorphism is associated with ESRD in autosomal dominant polycystic kidney disease patients
• Physical training at sub-threshold intensity reduces the prevalence of hepatic steatosis after high-fat diet in rats
• Incidence of the coracoclavicular joint in South African populations.